The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant chemotherapy (AC) use and outcomes in stage II colon cancer (CC) with and without poor prognostic features.
Aalok Kumar
No relevant relationships to disclose
Hagen F. Kennecke
No relevant relationships to disclose
Howard John Lim
No relevant relationships to disclose
Daniel John Renouf
No relevant relationships to disclose
Ryan Woods
No relevant relationships to disclose
Caroline Speers
No relevant relationships to disclose
Winson Y. Cheung
No relevant relationships to disclose